Ignite Creation Date:
2025-12-25 @ 4:28 AM
Ignite Modification Date:
2026-03-01 @ 12:23 AM
Study NCT ID:
NCT02945020
Status:
COMPLETED
Last Update Posted:
2025-02-03
First Post:
2016-10-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Pharmacokinetic Interaction Study Between Odalasvir, Given as a Single Agent or in Combination With Simeprevir, and Dabigatran Etexilate Mesylate in Healthy Participants
Sponsor:
Janssen Research & Development, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-11-10
Start Date Type:
ACTUAL
Primary Completion Date:
2017-01-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-01-20
Completion Date Type:
ACTUAL
First Submit Date:
2016-10-25
First Submit QC Date:
None
Study First Post Date:
2016-10-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-31
Last Update Post Date:
2025-02-03
Last Update Post Date Type:
ACTUAL